12 January 2022 in The Journal of Laryngology & Otology
RPRoberta Arb Saba Rodrigues Pinto
Roberta Arb Saba Rodrigues Pinto
Objective: Herpes zoster virus can cause inflammatory neuropathy of the facial nerve. However, studies evaluating the prevalence of this agent in peripheral facial palsy are heterogeneous regarding sample group selection, laboratory analysis method and variables studied. In addition, there are a lack of epidemiological data in the Brazilian population on this serological phenomenon in peripheral facial palsy. This study estimated herpes zoster reactivation prevalence in serological samples through chemiluminescence immunoassay for quantitative determination of specific antibodies directed against the virus.Methods: This cross-sectional study sought to determine the prevalence of viral reactivation by herpes zoster in subjects with idiopathic peripheral facial palsy through analysis of serological samples over a year.Results: Forty-seven patients (32 females and 15 males) participated. Severe paralysis was more common in older patients (p = 0.017). Facial pain (p = 0.02) and vertigo (p = 0.001) were related to a worse evolution of facial palsy. The rate of serological reactivation of the virus was 12.76 per cent.Conclusion: The rate of serological reactivation of herpes virus in idiopathic peripheral facial palsy in our population is similar to foreign literature data, suggesting similar aetiological mechanisms in the genesis of this morbidity.
29 November 2018 in Einstein (São Paulo)
Facial nerve hemangioma is a rare and benign vascular tumor, and accounts for 0.7% of intratemporal tumors. We report the second case described in the literature of a facial nerve hemangioma in its tympanic segment. A 14-year-old male patient presented with a history of progressive right ear hearing loss with preserved facial mimicry. Pure tone audiometry showed a right ear moderate conductive hearing loss. Magnetic resonance imaging demonstrated an expansive lesion involving the tympanic segment of the right facial nerve, suggestive of hemangioma. Watchful waiting was chosen as management. In the first case of middle ear facial hemangioma described in the literature, facial palsy was the symptom that led the patient to seek medical care. In the present case, it can be inferred that the first symptom was conductive hearing loss ipsilateral to the lesion. Facial palsy may not be present and the clinical presentation may resemble otosclerosis, ossicular chain disruption, and third window abnormalities, among other differential diagnoses of conductive hearing loss. The second case of tympanic portion facial nerve hemangioma is reported, describing the specificity of conductive hearing loss as its only clinical manifestation.
1 October 2018 in Revista da Sociedade Brasileira de Medicina Tropical
LCLudmilla Emilia Martins Costa
Ludmilla Emilia Martins Costa
It is known that in less than a third of patients presenting sudden hearing loss, the disorder can be attributed to viral infection, trauma, neoplasms, and vascular and autoimmune diseases. However, the role of the HIV in the onset of this disease has not yet been well described. A 46-year-old female, in an immunosuppression state induced by HIV infection, presented with sudden bilateral hearing loss, with no improvement despite treatment. Several mechanisms were reported by which the virus could induce damage to the auditory pathway. However, little is known regarding the prevention and treatment of this morbidity.
14 May 2025 in Brazilian Journal of Otorhinolaryngology
Children with Single-Sided Deafness (SSD) may experience a range of developmental challenges. While cochlear implantation has demonstrated significant improvements in hearing, its impact on Quality of Life (QoL) remains underreported. This review evaluates how cochlear implantation for SSD influences the quality of life in children. A systematic review was conducted following the PRISMA guidelines across nine different databases, without language restrictions, including articles indexed up to December 15, 2023. Eligible studies included patients up to 18-years-old; severe to profound unilateral hearing loss, and normal contralateral hearing; cochlear implantation with more than 3 months of follow-up; QoL assessed by structured questionnaires. Meta-analysis compared QoL scores obtained between pre- and post-operative periods for time of onset or hearing loss (congenital vs. post-lingual), evaluated by parents and children, and the effective cochlear implant usage time. A total of 296 articles were identified, with 6 eligible for qualitative analysis and 3 for meta-analysis, involving 187 patients. The mean age at implantation was 5.8 years, with an average auditory deprivation time of 3.8 years. Both the congenital and post-lingual groups demonstrated improvement in QoL, with a mean increase of 1.51 points in children's evaluations (p-value < 0.001) and 2.70 points in parental perspectives (p-value < 0.001), assessed on a 10-point scale. The estimated effective device use time was 8.8 h per day, with 8.55 h per day for the congenital group and 10.37 h per day for the post-lingual group. There was no statistically significant difference in usage time between the two groups (p-value = 0.140). The results indicated a significant improvement in QoL, as reported by both parents and through self-assessment. The treatment also demonstrated high levels of adherence. Both congenital and post-lingual groups yielded similar outcomes in terms of QoL and device usage time.